%A McHowat,Jane %A Shakya,Shubha %A Ford,David A. %D 2020 %J Frontiers in Physiology %C %F %G English %K Running title: 2-Chlorofatty aldehydes alter endothelial function Abbreviations: 2-ClFALD, 2-chlorofatty aldehyde,2-ClHDA, 2-chlorohexadecanal,2-ClHDyA, 2- chlorohexadec-15-ynal,HCAEC, human coronary artery endothelial cell,HDA, hexadecanal,HDyA, hexadec-15-ynal,MPO, myeloperoxidase,PFB-Br, pentafluorobenzyl bromide,VWF, von Willebrand factor Keywords: Endothelial cells, Fatty acids, Inflammation, Lipid mediators, Plasmalogens, Vascular biology,Chlorinated lipids,2-chlorofatty aldehyde,Myeloperoxidase,Click Chemistry,neutrophil adherence %Q %R 10.3389/fphys.2020.00460 %W %L %M %P %7 %8 2020-May-08 %9 Original Research %# %! 2-Chlorofatty aldehydes alter endothelial function %* %< %T 2-Chlorofatty Aldehyde Elicits Endothelial Cell Activation %U https://www.frontiersin.org/articles/10.3389/fphys.2020.00460 %V 11 %0 JOURNAL ARTICLE %@ 1664-042X %X Endothelial activation and dysfunction are hallmarks of inflammation. Neutrophil-vascular endothelium interactions have significant effects on vascular wall physiology and pathology. Myeloperoxidase (MPO)-derived products released from activated neutrophils can mediate the inflammatory response and contribute to endothelial dysfunction. 2-Chlorofatty aldehyde (2-ClFALD) is the direct oxidation product of MPO-derived hypochlorous acid (HOCl) targeting plasmalogen phospholipids. The role of 2-ClFALD in endothelial dysfunction is poorly understood and may be dependent on the vascular bed. This study compared the role of 2-ClFALD in eliciting endothelial dysfunction in human coronary artery endothelial cells (HCAEC), human lung microvascular endothelial cells (HLMVEC), and human kidney endothelial cells (HKEC). Profound increases in selectin surface expression as well as ICAM-1 and VCAM-1 surface expression were observed in HCAEC and HLMVEC. The surface expression of these adherence molecules resulted in robust adherence of neutrophils and platelets to 2-ClFALD treated endothelial cells. In contrast to HCAEC and HLMVEC, 2-ClFALD-treated HKEC had substantially reduced adherence molecule surface expression with no resulting increase in platelet adherence. 2-ClFALD-treated HKEC did have an increase in neutrophil adherence. All three endothelial cell lines treated with 2-ClFALD displayed a time-dependent loss of barrier function. Further studies revealed 2-ClHDyA localizes to ER and Golgi when using a synthetic alkyne analog of 2-ClFALD in HCAEC and HLMVEC. These findings indicate 2-ClFALDs promote endothelial cell dysfunction with disparate degrees of responsiveness depending on the vascular bed of origin.